Kabra; Bhagwati P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kabra; Bhagwati P..The latest application filed is for "aqueous pharmaceutical compositions containing borate-polyol complexes".

Company Profile

0.34.37

Kabra; Bhagwati P. - Euless TX
Kabra; Bhagwati P. - Arlington TX
Kabra; Bhagwati P. - Fort Worth TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical suspension Grant 9,707,173 - Kabra July 18, 2	2017-07-18
Finafloxacin suspension compositions Grant 9,504,691 - Boudreaux , et al. November 29, 2	2016-11-29
Aqueous Pharmaceutical Compositions Containing Borate-polyol Complexes App 20160324967 - Kabra; Bhagwati P.	2016-11-10
Finafloxacin Suspension Compositions App 20160279137 - Boudreaux; Brent G. ; et al.	2016-09-29
Aqueous pharmaceutical compositions containing borate-polyol complexes Grant 9,421,265 - Kabra August 23, 2	2016-08-23
Pharmaceutical compositions having desirable bioavailability Grant 9,144,561 - Kabra September 29, 2	2015-09-29
Aqueous Pharmaceutical Compositions Containing Borate-polyol Complexes App 20150224196 - Kabra; Bhagwati P.	2015-08-13
Aqueous pharmaceutical compositions containing borate-polyol complexes Grant 9,044,484 - Kabra June 2, 2	2015-06-02
Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye Grant 8,912,236 - Kabra , et al. December 16, 2	2014-12-16
Aqueous Pharmaceutical Compositions Containing Borate-polyol Complexes App 20140294750 - Kabra; Bhagwati P. ; et al.	2014-10-02
Pharmaceutical Compositions Having Desirable Bioavailability App 20140243409 - Kabra; Bhagwati P.	2014-08-28
Aqueous ophthalmic compositions containing anionic therapeutic agents Grant 8,785,497 - Kabra July 22, 2	2014-07-22
Pharmaceutical compositions having desirable bioavailability Grant 8,754,123 - Kabra June 17, 2	2014-06-17
Finafloxacin Suspension Compositions App 20140162990 - Boudreaux; Brent G. ; et al.	2014-06-12
Pharmaceutical compositions having desirable bioavailability Grant 8,722,735 - Kabra , et al. May 13, 2	2014-05-13
Pulsatile Peri-Corneal Drug Delivery Device App 20130261569 - Weiner; Alan L. ; et al.	2013-10-03
Pulsatile peri-corneal drug delivery device Grant 8,469,934 - Weiner , et al. June 25, 2	2013-06-25
Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye App 20130137741 - Kabra; Bhagwati P. ; et al.	2013-05-30
Topical ophthalmic compositions containing tobramycin and dexamethasone Grant 8,450,287 - Kabra May 28, 2	2013-05-28
Self-Preserved Aqueous Pharmaceutical Compositions App 20130053440 - Kabra; Bhagwati P. ; et al.	2013-02-28
Self-preserved aqueous pharmaceutical compositions Grant 8,323,630 - Kabra , et al. December 4, 2	2012-12-04
Pharmaceutical Compositions Having Desirable Bioavailability App 20120245227 - Kabra; Bhagwati P.	2012-09-27
Self preserved aqueous pharmaceutical compositions Grant 8,268,299 - Kabra , et al. September 18, 2	2012-09-18
Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection Grant 8,211,880 - Kabra , et al. July 3, 2	2012-07-03
Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use Grant 8,178,576 - Kabra , et al. May 15, 2	2012-05-15
Pharmaceutical compositions having desirable bioavailability Grant 8,178,582 - Kabra May 15, 2	2012-05-15
Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection App 20120115829 - Kabra; Bhagwati P. ; et al.	2012-05-10
Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection App 20120116216 - Kabra; Bhagwati P. ; et al.	2012-05-10
Topical Ophthalmic Compositions Containing Tobramycin And Dexamethasone App 20120077769 - Kabra; Bhagwati P.	2012-03-29
Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection Grant 8,128,960 - Kabra , et al. March 6, 2	2012-03-06
Pharmaceutical Compositions Having Desirable Bioavailability App 20120029073 - Kabra; Bhagwati P. ; et al.	2012-02-02
Topical ophthalmic compositions containing tobramycin and dexamethasone Grant 8,101,582 - Kabra January 24, 2	2012-01-24
Bioerodible film for ophthalmic drug delivery Grant 8,084,054 - Kabra , et al. December 27, 2	2011-12-27
Self-Preserved Aqueous Pharmaceutical Compositions App 20110195132 - Kabra; Bhagwati P. ; et al.	2011-08-11
Pulsatile Peri-corneal Drug Delivery Device App 20110184358 - Weiner; Alan L. ; et al.	2011-07-28
Aqueous Pharmaceutical Compositions Containing Borate-polyol Complexes App 20100324031 - Kabra; Bhagwati P.	2010-12-23
Topical Ophthalmic Compositions Containing Tobramycin And Dexamethasone App 20100286078 - Kabra; Bhagwati P.	2010-11-11
Aqueous Ophthalmic Compositions Containing Anionic Therapeutic Agents App 20100266713 - Kabra; Bhagwati P.	2010-10-21
Topical ophthalmic compositions containing tobramycin and dexamethasone Grant 7,795,316 - Kabra September 14, 2	2010-09-14
Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye App 20100226992 - Kabra; Bhagwati P.	2010-09-09
Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye App 20100227904 - Kabra; Bhagwati P. ; et al.	2010-09-09
Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye App 20100227905 - Kabra; Bhagwati P. ; et al.	2010-09-09
Pharmaceutical Suspension App 20100144719 - Kabra; Bhagwati P.	2010-06-10
Pharmaceutical compositions for otic use Grant 7,727,549 - Kabra June 1, 2	2010-06-01
Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use Grant 7,678,827 - Kabra , et al. March 16, 2	2010-03-16
Pharmaceutical Compositions Having Desirable Bioavailability App 20090234004 - Kabra; Bhagwati P. ; et al.	2009-09-17
Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions For Intravitreal Injection App 20090233890 - Kabra; Bhagwati P. ; et al.	2009-09-17
Pharmaceutical Compositions Having Desirable Bioavailability App 20090234013 - Kabra; Bhagwati P.	2009-09-17
Aqueous Pharmaceutical Compositions Containing Borate-polyol Complexes App 20090232763 - Kabra; Bhagwati P. ; et al.	2009-09-17
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions For Intraocular Use App 20080241224 - Kabra; Bhagwati P. ; et al.	2008-10-02
2-pyrrolidone Derivatives For Preservation Of Ophthalmic, Otic And Nasal Compositions App 20080095863 - Kabra; Bhagwati P.	2008-04-24
Packaging Materials For Formulations Containing 2-pyrrolidone Derivatives App 20080093247 - Han; Wesley Wehsin ; et al.	2008-04-24
Self Preserved Aqueous Pharmaceutical Compositions App 20080075790 - Kabra; Bhagwati P. ; et al.	2008-03-27
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use App 20070184089 - Howie; Janet D. ; et al.	2007-08-09
Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure App 20060073172 - Schneider; L. Wayne ; et al.	2006-04-06
Bioerodible film for ophthalmic drug delivery App 20040126408 - Kabra, Bhagwati P. ; et al.	2004-07-01
Pharmaceutical compositions for otic use App 20040014819 - Kabra, Bhagwati P.	2004-01-22
Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use App 20040013704 - Kabra, Bhagwati P. ; et al.	2004-01-22
Topical composition comprising ciprofloxacin and hydrocortisone App 20020037884 - Singh, Onkar N. ; et al.	2002-03-28
Gelling ophthalmic compositions containing xanthan gum Grant 6,261,547 - Bawa , et al. July 17, 2	2001-07-17
Gelling ophthalmic compositions containing xanthan gum Grant 6,174,524 - Bawa , et al. January 16, 2	2001-01-16
Thermally-gelling emulsions Grant 5,827,835 - Kabra October 27, 1	1998-10-27
Thermally-gelling drug delivery vehicles containing cellulose ethers Grant 5,618,800 - Kabra , et al. April 8, 1	1997-04-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.